Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/27/2003WO2002094283A3 Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085180A3 Vasectomy procedure and related kit
11/27/2003WO2002079170A3 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them
11/27/2003WO2002078730A3 Use of neublastin polypeptides for treating neuropathic pain
11/27/2003WO2002074735A3 Biurethane derivatives
11/27/2003WO2002072095A3 Tiotropium salts for treating inflammatory diseases
11/27/2003WO2002072020A3 Novel anti-adhesive compounds and uses thereof
11/27/2003WO2002070014A8 Compositions comprising an o/w emulsion containing conjugated linoleic acid
11/27/2003WO2002069987A3 Agent for treating diabetes mellitus
11/27/2003WO2002067903A3 Compositions and methods of manufacture for oral dissolvable dosage forms
11/27/2003WO2002066617A8 Method for detecting a risk of hypertension and uses thereof
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002062302A3 Steroidal derivatives
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002060393B1 Proteoglycan compositions for treatment of inflammatory conditions
11/27/2003WO2002057242A3 Urea derivatives as integrin alpha 4 antagonists
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2002046424A3 Fibroblast growth factors
11/27/2003WO2001078727A8 Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia
11/27/2003WO2000062735A3 Treatment of neoplasms with viruses
11/27/2003US20030220508 An enzyme inhibitor for treating AIDS, viral infections
11/27/2003US20030220506 A 7-(5-oxo-pyrrolidin-1-yl)-heptanoic acid or ester derivatives for therapeutic treatment of eye hypertension or glaucoma
11/27/2003US20030220504 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
11/27/2003US20030220501 A chemical intermediates for making phthalimidoamlodipine, and further deprotecting to form amlodipine calcium channel blockers
11/27/2003US20030220496 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate
11/27/2003US20030220495 Inhibitors of farnesyl protein transferase
11/27/2003US20030220494 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/27/2003US20030220493 Selectively inhibit binding to the alpha -1a adrenergic receptor; chemical intermediates
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220468 Modified forms of pharmacologically active agents and uses therefor
11/27/2003US20030220405 DNA encoding an epsilon, epsilon-lycopene cyclase from romaine lettuce
11/27/2003US20030220403 Mixtures of 2-((diphenylmethyl) sulfinyl) acetamide, diluents, disintegrants, binders and lubricants, mixed to form solid dosages suitable for oral administration
11/27/2003US20030220402 Secondary carbocyclic amides such as 2-(4-(2-naphthyloxy)-benzamido)benzoic acid methyl ester, used as anticarcinogenic agents
11/27/2003US20030220401 Modulation of signal transduction
11/27/2003US20030220399 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia
11/27/2003US20030220398 Administering rosmarinic acid, curcumin, phenethyl caffeate or 3-caffeoylquinic acid as hypotensive agents
11/27/2003US20030220397 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
11/27/2003US20030220396 Method for treating ocular hypertension and glaucoma
11/27/2003US20030220395 Applying eye drops comprising prostaglandin derivatives such as 15-oxo-16-(3-trifluoromethyl phenoxy)-17,18,19,20-tetranor PGF2 alpha isopropyl ester, as hypotensive agents for prophylaxis of vision defects
11/27/2003US20030220393 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them
11/27/2003US20030220392 Prophylaxis of bacterial infections by administering 2'-(6-Chloropiperonyl)-3-(2,6-dichlorobenzyloxy)cinnamic acid and/or racemic mixtures, as antibiotics
11/27/2003US20030220391 Taxoids such as 3'-tert-butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N -debenzoyl-4-O-methoxycarbonyl-paclitaxel, used as antitumor agents
11/27/2003US20030220390 Carbocyclic oxy amines such as 2-benzylidene-6-dimethylamino methylcyclohexanone, used as analgesics
11/27/2003US20030220389 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220387 Nitrogen compounds such as 3,9-Difluoro-12,13-dihydro-13-((3,6 -anhydro)-beta-D- glucopyranosyl)-5H-indolo(2,3-a)pyrrolo(3,4 -c)carbazole-5,7(6H)-dione, used as topoisomerase inhibitors, antiproliferative or antitumor agents
11/27/2003US20030220385 Nitrogen compounds such as 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)-6-fluoroindazole, administered as phosphodiesterases inhibitors for prophylaxis of cardiovascular or sexual disorders, or as hypotensive agents
11/27/2003US20030220384 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
11/27/2003US20030220383 Administering transport protein antagonists such as 4'-(5-formyl-4-(2-methoxyethoxy)-2-phenyl-1-imidazolylmethyl)-3' -methylsulfonylbiphenyl-2-sulfonylcyanamide and cariporide, an anticoagulants and antiinflammatory agents
11/27/2003US20030220382 Amines such as 2-((2-N,N-di-n-pentylamino)-indan-5-yl)amino-5 -nitro-benzoic acid, administered for prophylaxis of Alzheimer's disease
11/27/2003US20030220381 Administering to a mammal 8-(5-Methyl-2-phenyl-oxazol-4-yl)-2-(1,2,3)triazoles, or 8-(5-methyl-2-phenyl-oxazol-4-yl)-2-pyrrol-1-yl- derivative for treating, obesity, hyperglycemia, diabetes etc
11/27/2003US20030220379 Fermentative preparation process for and crystal forms of cytostatics
11/27/2003US20030220378 Oral administration of epothilones
11/27/2003US20030220376 Administering a carbo or heterocyclic compound having a sulfonamide group to a patient to treat carbonic anhydrase mediated diseases such as elevated intraocular pressure, edema, altitude sickness and periodic paralyis
11/27/2003US20030220375 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
11/27/2003US20030220374 Thiazolidinediones or oxazolidinediones as peroxisome proliferator-activated receptor-gamma agonist, useful for treating or inhibiting pain, inflammation, or inflammation related disease and inhibition of cancer
11/27/2003US20030220373 Therapeutic uses of PPAR mediators
11/27/2003US20030220372 Imidazole compounds as anti-inflammatory and analgesic agents
11/27/2003US20030220371 Administering to a mammal an aromatic or heteroaromatic ring substituted triazole derivative to treat the conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, and obesity
11/27/2003US20030220368 Superior Na+ channel inhibition activity; antiarrhythmic agents
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220366 Nicotinamide derivatives useful as PDE4 inhibitors
11/27/2003US20030220364 New compounds
11/27/2003US20030220363 L-carnitine or salt exerts an adjuvant action for the anticancer activity
11/27/2003US20030220362 Novel inhibitors of formation of advanced glycation endproducts (AGEs)
11/27/2003US20030220361 Administering together tiotropium salt and substituted 3-amidopyridine derivatives for treating inflammation, allergic and respiratory diseases
11/27/2003US20030220360 Tricyclic condensed heterocyclic compounds containing o, s in the ring, and atleast one hydroxy group, useful as antiasthmatic drugs
11/27/2003US20030220359 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
11/27/2003US20030220358 A1 adenosine receptro antagonists
11/27/2003US20030220356 ABCA-1 elevating compounds
11/27/2003US20030220354 Quinazoline ditosylate salt compounds
11/27/2003US20030220353 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/27/2003US20030220351 Enteric coating made of methacrylic acid copolymer; system may also include a subcoating; resists disintegration and release of caffeine at pH less than 5, but disintegrates rapidly to release caffeine at pH greater than 6
11/27/2003US20030220349 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists
11/27/2003US20030220348 Substituted imidazolylmethyl pyridine and pyrazine deriviatives GABAa receptor ligands
11/27/2003US20030220347 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
11/27/2003US20030220346 Use of bioactive metabolites of gepirone for the treatment of psychological disorders
11/27/2003US20030220345 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimdin-7-ones
11/27/2003US20030220344 Method of treating arrhythmias
11/27/2003US20030220343 Lowering the total amount of cholesterol in the blood using mixture of pravastatin and one or more vitamins selected from riboflavins, d-alpha-tocopherols, ascorbic acids and inositol hexanicotinate
11/27/2003US20030220342 Use of such compounds as corticotropin releasing factor receptor antagonists in the treatment of various neurological disorders
11/27/2003US20030220341 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/27/2003US20030220339 Heterocyclic arylsulfonamidobenzylic compounds
11/27/2003US20030220338 Fungal efflux pump inhibitors
11/27/2003US20030220336 Use of p38 kinase inhibitors for preparation of pharmaceutical composition suitable for inhalation therapy
11/27/2003US20030220335 Benzoxazines for use in the treatment of parkinson's disease
11/27/2003US20030220332 Useful in the treatment of inter alia benign prostatic hyperplasia
11/27/2003US20030220331 6-Azauracil derivatives as IL-5 inhibitors
11/27/2003US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
11/27/2003US20030220329 Method of improving beta-adrenergic receptor function
11/27/2003US20030220326 Compounds, pharmaceutical compositions, and methods for inhibiting cyclin-dependent kinases
11/27/2003US20030220325 Such as 1-(4-(phenylsulfonyl)-naphthyl)piperazine; for treating treating diseases related to 5-HT receptor; radiolabelling
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220323 Such as (2-(4-(2-(1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy)-1-phenyl-ethyl) -piperazin-1-yl)-ethoxy)-acetic acid; for prevention and/or treatment of conditions associated with pathogical levels of substance P
11/27/2003US20030220322 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use
11/27/2003US20030220321 Such as 10-(2-ethoxyphenyl)-1,2,3,4,5,6-hexahydroazepino(4,5-b)indole; for treatment of anxiety, depression, schizophrenia, epilepsy, migraine, Alzheimers disease, sleep disorders, obesity, stress related diseases, and/or drug withdrawal
11/27/2003US20030220320 Ningalin b analogs employable for reversing multidrug resistance
1 ... 5261 5262 5263 5264 5265 5266 5267 5268 5269 5270 5271 5272 5273 5274 5275 5276 5277 5278 5279 5280 5281 ... 7860